Global Microbial biopharmaceuticals Market: By Microbe Type (Bacteria, Fungal & Yeast, Virus), By End product (Vaccines, Hormones, Antibody derived proteins, PEGylated products, BL-2 Products), By Application (Metabolic Disorders, Hormonal disorders, homological disorders, Oncological disorders) and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global microbial biopharmaceuticals market was valued round US$ 308 Bn in 2020 and poised to grow at significant CAGR of 14.7% over 2021-2027. microbial biopharmaceuticals market Increase in geriatric population, changes in life styles are increasing the demand for biopharmaceuticals. Increase in research facilities, more approved biopharmaceutical products in market are also key factors effecting the market. Frequent cases of side effects and incompatibilities in cases of mammalian or plant obtained biopharmaceutical products causes the rise in demand for microbial products as they do not possess any side effects. They can be manufactured easily with low cost and are more stable in atmospheric and biological conditions. Microbes have been used to make bread, wine, vinegar, and other common items for millennia, with no one knowing the scientific basis. Nonmicrobial goods such as insulin, interferon, human growth hormone, and viral vaccinations are now commercially produced using genetically altered organisms. Microbes are also employed to produce energy (biodiesel and bioethanol), as well as to clean up contaminants like sewage and oil spills. Microorganisms contribute to increased agricultural production as active ingredients in biofertilizers and biopesticides, and microbes are the foundation of cost-effective mining and metallurgical technologies. Global microbial biopharmaceuticals market is surging owing to frequent acquisitions and launchings by the market players. For Instance, in 2013, Sanofi a French pharmaceutical company announced that a strain of baker’s yeast capable of producing malaria drugs on an industrial scale had successfully engineered by their researchers and it is commercially available now.

Microbial Biopharmaceuticals Market Summary

Study Period

2023-29

Base Year

2022

CAGR

14.7%

Largest Market

North-America

Fastest Growing Market

Asia pacific
Growth

Microbial biopharmaceuticals are simply defined as the biopharmaceutical products which are extracted from microbial species by using recombinant DNA technology. These products have various benefits when compared to other biopharmaceutical products such as easy manufacture and extraction, low of cost, more stability, high potency, no or very less side effects and high therapeutic nature etc. thus, the market for these microbial biopharmaceuticals are showing significant growth.

Key Features of the Reports

  • Global microbial biopharmaceuticals market expanding at significant CAGR over 2020 to 2026 due to their high potency, easy manufacturing and less side effects.
  • Based on end products, Vaccines segment accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global microbial biopharmaceuticals market

Microbial Biopharmaceuticals Market Segmentation

By Microbe Type
  • Bacteria
  • Fungal & Yeast
  • Virus
  • Other microbes
By End Product
  • Vaccines
  • Hormones
  • Antibody derived proteins
  • PEGylated products
  • BL-2 Products
By Application
  • Metabolic disorders
  • Hormonal disorders
  • Hematological disorders
  • Oncological disorders
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Table of Content
  1. Executive Summary
  2. Global Microbial biopharmaceuticals Market Introduction
    • Global Microbial biopharmaceuticals Market – Taxonomy
    • Global Microbial biopharmaceuticals Market –Definitions
      • By Microbe Type
      • By End Product
      • By Applications
  1. Global Microbial biopharmaceuticals Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Microbial biopharmaceuticals Market Dynamic Factors - Impact Analysis
    • Global Microbial biopharmaceuticals Market – Competition Landscape
  2. Global Microbial biopharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Microbial biopharmaceuticals Market, By Microbe Type, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Bacterial Products
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Fungal & Yeast Products
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Virus Products
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other microbes
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Microbial biopharmaceuticals Market Forecast, By End Products, 2015 - 2019 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Vaccines
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hormones
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antibody derived proteins
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • PEGylated products
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • BL-2 products
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Microbial Biopharmaceuticals Market Forecast, By Application, 2015 - 2019 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Metabolic disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hormonal disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hematological disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Oncological disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Microbial biopharmaceuticals Market Forecast, By Region, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Microbial biopharmaceuticals Market - Opportunity Analysis Index, By Microbe Type, End Product, Application, and Region, 2020 - 2026
  2. North America Microbial biopharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Microbe type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bacteria
      • Fungal & Yeast
      • Virus
      • Other microbes
    • End products Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Vaccines
      • Harmones
      • Antibody derived proteins
      • PEGylated products
      • BL-2 Products
    • Application Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metabolic disorders
      • Harmonal disorders
      • Hematological disorders
      • Oncological disorders
      • Others
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • USA
      • Canada
    • North America Microbial biopharmaceuticals Market - Opportunity Analysis Index, By Microbe Type, End Product, Application, and Country, 2020 - 2026
    • North America Microbial biopharmaceuticals Market Dynamics – Trends
  3. Europe Microbial biopharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Microbe type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bacteria
      • Fungal & Yeast
      • Virus
      • Other microbes
    • End products Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Vaccines
      • Harmones
      • Antibody derived proteins
      • PEGylated products
      • BL-2 Products
    • Application Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metabolic disorders
      • Harmonal disorders
      • Hematological disorders
      • Oncological disorders
      • Others
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Microbial biopharmaceuticals Market - Opportunity Analysis Index, By Microbe Type, End Product, Application, and Country, 2020 - 2026
    • Europe Microbial biopharmaceuticals Market Dynamics – Trends
  4. Asia-Pacific Microbial biopharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Microbe type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bacteria
      • Fungal & Yeast
      • Virus
      • Other microbes
    • End products Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Vaccines
      • Harmones
      • Antibody derived proteins
      • PEGylated products
      • BL-2 Products
    • Application Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metabolic disorders
      • Harmonal disorders
      • Hematological disorders
      • Oncological disorders
      • Others
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Microbial biopharmaceuticals Market - Opportunity Analysis Index, By Microbe Type, End Product, Application, and Country, 2020 - 2026
    • Asia-Pacific Microbial biopharmaceuticals Market Dynamics – Trends
  5. Latin America Microbial biopharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Microbe type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bacteria
      • Fungal & Yeast
      • Virus
      • Other microbes
    • End products Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Vaccines
      • Harmones
      • Antibody derived proteins
      • PEGylated products
      • BL-2 Products
    • Application Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metabolic disorders
      • Harmonal disorders
      • Hematological disorders
      • Oncological disorders
      • Others
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Latin America Microbial biopharmaceuticals Market - Opportunity Analysis Index, By Microbe Type, End Product, Application, and Country, 2020 - 2026
    • Latin America Microbial biopharmaceuticals Market Dynamics – Trends
  6. Middle East and Africa Microbial biopharmaceuticals Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Microbe type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Bacteria
      • Fungal & Yeast
      • Virus
      • Other microbes
    • End products Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Vaccines
      • Harmones
      • Antibody derived proteins
      • PEGylated products
      • BL-2 Products
    • Application Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metabolic disorders
      • Harmonal disorders
      • Hematological disorders
      • Oncological disorders
      • Others
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Microbial biopharmaceuticals Market - Opportunity Analysis Index, By Microbe Type, End Product, Application, and Country, 2020 - 2026
    • MEA Microbial biopharmaceuticals Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • AbbVie Inc. (Abbott)
      • A-Bio Pharma Pte Ltd.
      • ABL, Inc.
      • Affinity Life Sciences, Inc.
      • Ajinomoto Aminoscience, LLC
      • Alexion Pharmaceuticals
      • Alliance Medical Products, Inc.
      • Alpha Biologics
      • Baxter BioPharma Solutions/Baxter Bioscience
      • Biogen Idec
      • BIOMEVA GmbH
      • Biotecnol
      • Boehringer Ingelheim GmbH
      • Boston Mountain Biotech
      • Celonic
      • Crucell /Johnson & Johnson
      • FUJIFILM Diosynth Biotechnologies
      • Genentech/Roche
      • GlaxoSmithKline
      • Glycobia
      • Lonza AG
      • Merck & Co. Inc
      • Novartis
      • Pfizer
      • ProBioGen AG
      • Regeneron Pharmaceuticals
      • Rentschler Biotechnologie
      • Royal DSM
      • Sandoz
      • Sanofi Pasteur
      • Sutro Biopharma
  1. Research Methodology
  2. Key Assumptions and Acronyms
  Disclaimer The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.
  • AbbVie Inc. (Abbott)
  • A-Bio Pharma Pte Ltd.
  • ABL, Inc.
  • Affinity Life Sciences, Inc.
  • Ajinomoto Aminoscience, LLC
  • Alexion Pharmaceuticals
  • Alliance Medical Products, Inc.
  • Alpha Biologics
  • Baxter BioPharma Solutions/Baxter Bioscience
  • Biogen Idec
  • BIOMEVA GmbH
  • Biotecnol
  • Boehringer Ingelheim GmbH
  • Boston Mountain Biotech
  • Celonic
  • Crucell /Johnson & Johnson
  • FUJIFILM Diosynth Biotechnologies
  • Genentech/Roche
  • GlaxoSmithKline
  • Glycobia
  • Lonza AG
  • Merck & Co. Inc
  • Novartis
  • Pfizer
  • ProBioGen AG
  • Regeneron Pharmaceuticals
  • Rentschler Biotechnologie
  • Royal DSM
  • Sandoz
  • Sanofi Pasteur